EcoDrugPlus

Bcl2 Related Protein A1

Ensembl ID : ENSFCAG00000012928
Gene Symbol: BCL2A1
5 Cross references
133 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSFCAG00000002050
Gene Symbol: BCR
5 Cross references
286 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSFCAG00000015395
Gene Symbol: BTK
3 Cross references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSFCAG00000006828
Gene Symbol: CCR1
5 Cross references
158 Possible Orthologues:

C-C Motif Chemokine Receptor 4

Ensembl ID : ENSFCAG00000002919
Gene Symbol: CCR4
3 Cross references
113 Possible Orthologues:

C-C Motif Chemokine Receptor 5

Ensembl ID : ENSFCAG00000049013
Gene Symbol: CCR5
4 Cross references
147 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSFCAG00000042611
Gene Symbol: CCR9
5 Cross references
265 Possible Orthologues:

C-X-C Chemokine Receptor Type 2

Ensembl ID : ENSFCAG00000026553
Gene Symbol: LOC101085650
4 Cross references
269 Possible Orthologues:

C-X-C Motif Chemokine Ligand 8

Ensembl ID : ENSFCAG00000004666
Gene Symbol: CXCL8
5 Cross references
139 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSFCAG00000015575
Gene Symbol: CXCR4
5 Cross references
218 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSFCAG00000014955
Gene Symbol: CFTR
5 Cross references
217 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSFCAG00000012246
Gene Symbol: DNMT1
5 Cross references
212 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).